Skip to content

JAS Diagnostics DG-TRI2-1L

by Drew Scientific, Ltd.

JAS Diagnostics DG-TRI2-1L is a triglyceride IVD (FDA Class I; FDA product code CDT, Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides) made by Drew Scientific, Ltd., listed in FDA GUDID since 12 Sep 2016 (UDI-DI 00817274022030), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00817274022030 UDI-DI Date12 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
TRIGLYCERIDES LIQUID (1 x 1 Liter + 1 x 5 mL Standard)
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
JAS Diagnostics
Generic name
Triglyceride IVD, reagent
Model / reference
DG-TRI2-1L
Primary DI / UDI-DI
00817274022030
FDA product code
CDT
GMDN term
Triglyceride IVD, reagent
Device class
Class I
Regulation number
862.1705
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Triglyceride IVD, reagent.

Other devices from Drew Scientific, Ltd.

See all devices from Drew Scientific, Ltd. →

Properties

  • Convenience kit
  • Premarket exempt
  • Lot / batch number
Other properties (12, all answered No)